ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,799,000 | +39.7% | 91,800 | +1.9% | 0.94% | +5.7% |
| Q2 2021 | $11,307,000 | -7.5% | 90,100 | 0.0% | 0.89% | -16.0% |
| Q1 2021 | $12,219,000 | -1.7% | 90,100 | -7.3% | 1.06% | +8.8% |
| Q4 2020 | $12,436,000 | +33.1% | 97,200 | +17.1% | 0.97% | +27.3% |
| Q3 2020 | $9,340,000 | +50.8% | 83,000 | +27.7% | 0.76% | -4.4% |
| Q2 2020 | $6,192,000 | +658.8% | 65,000 | +170.8% | 0.80% | +128.6% |
| Q2 2016 | $816,000 | – | 24,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |